2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

Insulin resistance is often associated with obstructive sleep apnoea syndrome (OSAS) and could contribute to cardiovascular risk in OSAS. Sleep loss and intermittent hypoxia could contribute to the pathogenesis of the metabolic alterations associated with obesity, a common feature of OSAS. The biology of the adipocyte is being increasingly studied, and it has been found that hypoxia negatively affects adipocyte function.

This Research Seminar aimed at discussing:

the effects of hypoxia on glucose metabolism and adipocyte function
the role of inflammatory activation in OSAS and obesity
the alarming rates of obesity and OSAS in children
the harmful effects of the metabolic syndrome in OSAS
the effects of OSAS treatment on metabolic variables
the relationship between daytime sleepiness and hormonal and inflammatory responses.

2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Metabolic effects of OSAS and cardiovascular risk

M. Bonsignore (Palermo, Italy)

Slides

Accompanying documents

Is OSAS a systemic disease?

A. Vgontzas (Hershey, Pa, United States of America)

Slides

Accompanying documents

Obesity in children: a model for early aspects and prevention of OSAS

W. Kiess (Leipzig, Germany)

Accompanying documents

Sleep-disordered breathing and metabolic alterations in children

S. Verhulst (Wilrijk, Belgium)

Slides

Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS?

R. Tkacova (Kosice, Slovakia)

Accompanying documents

Endocrine function of adipose tissue

P. Trayhurn (Liverpool, United Kingdom)

Accompanying documents

Adipose tissue and muscle insulin resistance

J. Eckel (Duesseldorf, Germany)

Accompanying documents

Inflammation and vascular dysfunction

B. Staels (Lille, France)

Accompanying documents

Biological Specificity of Visceral Adipose Tissue and Therapeutic Intervention

F. Giorgino (Bari, Italy)

Slides

Accompanying documents

Intermittent hypoxia in sleep apnea: a cause of inflammatory activation

W. McNicholas (Dublin, Ireland)

Slides

Accompanying documents

Biology of peripheral blood inflammatory cells in OSAS

L. Lavie (Haifa, Israel)

Slides

Excessive daytime somnulence, obesity and inflammation

A. Vgontzas (Hershey, Pa, United States of America)

Slides

Accompanying documents

The development of insulin resistance in a murine model of intermittent hypoxia

C. O'Donnell (Pittsburgh, United States of America)

Slides

Accompanying documents

CDN Connection Issue

2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

#{title}